LEXINGTON, Mass. and AMSTERDAM, Jan. 08, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, ...
LEXINGTON, Mass. and AMSTERDAM, Jan. 08, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, ...
Discover Weiss/Manfredi's architectural journey from award-winning designs to innovative landscape urbanism in New York and beyond.
Fintel reports that on January 7, 2025, Guggenheim downgraded their outlook for Palo Alto Networks (NasdaqGS:PANW) from ...
Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its ...
Closeout retailer completes deal that will save up to 400 of its approximately 950 stores from going out of business ...
Internationally recognized investor and entrepreneur Kevin O'Leary joins forces with The People's Bid for TikTok, an effort ...
As previously reported, Guggenheim analyst John DiFucci upgraded Workday (WDAY) to Neutral from Sell with no price target While the firm still ...
The depth of winter is a fertile time for creative endeavors, a quiet time when artists can explore the interior depth of ...
In the digital realm, the guggenheim-bilbao.eus website recorded a total of 2.893.452 visits and 10.850.342 page views in 2024. The Museum continues to expand its community and influence on social ...
NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution schedule ...